Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 5161 AL 5175

LRRK2 Degraders for Parkinson's Disease and Inflammation: Tau and α‑Synuclein Degraders for Neurodegeneration

Renner AC, Kargbo RB.

ACS Med Chem Lett. 2025 Oct 10;16(11):2171-2174. doi: 10.1021/acsmedchemlett.5c00594. eCollection 2025 Nov 13.

Novel 2H‑Pyrazolo[3,4‑d]thiazole Compounds Targeting NLRP3 for the Treatment of Neurodegenerative Diseases

Song Z, Liang SH.

ACS Med Chem Lett. 2025 Nov 3;16(11):2200-2201. doi: 10.1021/acsmedchemlett.5c00626. eCollection 2025 Nov 13.

Inhibitors of Stearoyl-Coenzyme A Desaturase 1 and 5 May Provide a Novel Therapeutic Strategy for the Treatment of Neurological Disorders and Brain Cancer

Abdel-Magid AF.

ACS Med Chem Lett. 2025 Oct 26;16(11):2191-2193. doi: 10.1021/acsmedchemlett.5c00619. eCollection 2025 Nov 13.

Cone repair and right ventricular resection in an adult patient with Ebstein's anomaly

Torchio F, Varrica A, Chessa M, Giamberti A.

Multimed Man Cardiothorac Surg. 2025 Nov 19;2025. doi: 10.1510/mmcts.2025.116.

Treatment-Emergent Parkinsonism in Four Patients Treated with Chimeric Antigen Receptor T-Cell Therapy

Sanderson JB, Lin YH, Su K, Wang Y, Portuguese A, Gauthier J, Durbin M, Banerjee R.

Mov Disord Clin Pract. 2025 Nov 19. doi: 10.1002/mdc3.70452. Online ahead of print.

A review of the evidence for a protective role of uric acid in Parkinson's disease

Liu H, Reynolds GP.

NPJ Parkinsons Dis. 2025 Nov 19;11(1):325. doi: 10.1038/s41531-025-01169-8.

Synuclein Proteoforms: Role in Health and Disease

Zahra FT, Kayani H, Noreen S, Noor A, Zafar S.

Mol Neurobiol. 2025 Nov 19;63(1):87. doi: 10.1007/s12035-025-05359-6.

Author Correction: A blood-based DNA damage signature in patients with Parkinson's disease is associated with disease progression

Sproviero D, Payán-Gómez C, Milanese C, Barnhoorn S, Sun S, Gyenis A, Delia D, Lashley T, Hoeijmakers JHJ, Vijg J, Mastroberardino PG.

Nat Aging. 2025 Dec;5(12):2564. doi: 10.1038/s43587-025-01037-3.

Nrf2-Keap1 Pathway and NLRP3 Inflammasome in Parkinson's Disease: Mechanistic Crosstalk and Therapeutic Implications

Jain R, Vora L, Nathiya D, Khatri DK.

Mol Neurobiol. 2025 Nov 20;63(1):91. doi: 10.1007/s12035-025-05389-0.

[Effects of acupoint catgut embedding on gut microbiota and fecal short-chain fatty acids in Parkinson's disease patients with constipation]

Zhang X, Jiang J, Li W, Chen J, Huang Y, Ren W, Song Y, Sun J.

Zhongguo Zhen Jiu. 2025 Nov 12;45(11):1533-1540. doi: 10.13703/j.0255-2930.20241118-k0003. Epub 2025 Feb 6.

Assessing the potential causal influence of myasthenia gravis on neurodegenerative diseases via multivariable Mendelian randomization

Huang X, Wang X, Yang Y, Chen H.

Medicine (Baltimore). 2025 Oct 31;104(44):e45340. doi: 10.1097/MD.0000000000045340.

A rare case report of acute severe hypokalemia induced by monosialotetrahexosylganglioside therapy

Zheng X, He J.

Medicine (Baltimore). 2025 Oct 31;104(44):e45275. doi: 10.1097/MD.0000000000045275.

Cognitive behavioral therapy for insomnia in neurodegenerative disorders-targeting sleep disturbances in Alzheimer's and Parkinson's disease: a scoping review

Latella D, Calderone A, Casella C, De Luca R, Gangemi A, Impellizzeri F, Caliri S, Quartarone A, Calabrò RS.

Front Psychol. 2025 Nov 4;16:1700496. doi: 10.3389/fpsyg.2025.1700496. eCollection 2025.

The role of presynaptic dopaminergic imaging in acquired neurological conditions affecting basal ganglia: a systematic review

Ardila Jurado E, Zünd-Hofer L, Brugger F, Nicastro N, Bhatia KP, Kägi G.

Front Neurol. 2025 Nov 4;16:1660747. doi: 10.3389/fneur.2025.1660747. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias